Menu
Enrolling by invitation NCT06749509

Effects of Musculoskeletal Rehabilitation Courses on Work Ability

Observational Musculoskeletal Diseases or Conditions Musculoskeletal Disorders

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Face-to-face musculoskeletal rehabilitation, Musculoskeletal telerehabilitation, Controls.
Who it may be relevant to
Registry conditions: Musculoskeletal Diseases or Conditions, Musculoskeletal Disorders. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Finland
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Effects of Musculoskeletal Rehabilitation Courses on Work Ability (Tules-kurssit Ja Työkyky)

Overview

The goal of this observational study is to learn about the effects of two different musculoskeletal rehabilitation programs in working-age people with musculoskeletal disorders. The main question it aims to answer is: Do musculoskeletal rehabilitation programs A or B improve work ability in people with musculoskeletal disorders? Participants starting in rehabilitation programs A and B will answer survey questions about their work ability and related factors three times: when starting, immediately after the rehabilitation ends, and 4 months after ending the rehabilitation. Participants in study group C will answer the same questions during the same time period. Researchers will compare participants in rehabilitation programs A and B to participants in group C, who have musculoskeletal disorders but will not participate in rehabilitation programs. The comparison is done to see if there are differences in the changes in work ability and related factors, such as pain or quality of life.

Interventions

  • Other Face-to-face musculoskeletal rehabilitation
    Kela's rehabilitation course for those with MSD includes two 5-day periods and one 3-day period of face-to-face rehabilitation, which are carried out in a Finnish rehabilitation center over a 9-month period and implemented by a multidisciplinary team of rehabilitation experts. The rehabilitation course is group-based and provided free of charge. The 9-month rehabilitation period also includes calls to the participants before and after rehabilitation. The course is intended for persons over the a
  • Other Musculoskeletal telerehabilitation
    Kela´s MSD telerehabilitation course is arranged entirely as telerehabilitation, and it includes videoconferencing, online rehabilitation, and group-based rehabilitation days implemented by a multidisciplinary team of rehabilitation experts. Participation does not require particular IT skills, but appropriate equipment (e.g., mobile phone, laptop, tablet computer) is needed. The rehabilitation course is free of charge, and the total duration, including the calls before and after rehabilitation,
  • Other Controls
    The control participants have an MSD diagnosis and musculoskeletal symptoms. Based on an occupational physiotherapist's brief evaluation they are eligible to apply for Kela's musculoskeletal rehabilitation (the interventions below). By them own choice, however, they will not participate in these rehabilitation programs in the near future. The controls are recruited via two occupational health care producers in the private sector.

Primary outcome measures

  • Change from Baseline in Work Ability at 4-6 Months and 8-10 Months [Time frame: Baseline (pre-intervention), 4-6 months (after the intervention), 8-10 months (4-month follow-up)]
Secondary outcome measures (7)
  • Change from Baseline in Mood at 4-6 months [Time frame: Baseline (pre-intervention), 4-6 months (after the intervention)]
  • Change from Baseline in Quality of Life at 4-6 months [Time frame: Baseline (pre-intervention), 4-6 months (after the intervention)]
  • Change from Baseline in Functional Ability at 4-6 months [Time frame: Baseline (pre-intervention), 4-6 months (after the intervention)]
  • Change from Baseline in Pain at 4-6 months and 8-10 months [Time frame: Baseline (pre-intervention), 4-6 months (after the intervention), 8-10 months (4-month follow-up)]
  • Change from Baseline in Return-to-Work Self Efficacy at 4-6 months [Time frame: Baseline (pre-intervention), 4-6 months (after the intervention)]
  • Invidual Goal Achievement [Time frame: 4-6 months (after intervention)]
  • Days Lost Through Sickness [Time frame: Between January 1, 2024 and June 30, 2026]

Eligibility criteria

Inclusion criteria

Groups 1 ja 2:

  • diagnosed musculoskeletal disorder
  • 18 years or older
  • in employment, returning to work, studying, or receives rehabilitation subsidy
  • participating in either of the following:
  • Kela's face-to-face musculoskeletal rehabilitation (A)
  • Kela's musculoskeletal telerehabilitation (B)
  • willingness to participate in the study

Group 3 (Controls):

  • diagnosed musculoskeletal disorder
  • 18 years or older
  • in employment, returning to work, studying, or receives rehabilitation subsidy
  • musculoskeletal symptoms have lasted at least 3 months and the person has participated in physiotherapy or self-rehabilitation without satisfactory results
  • willingness to participate in the study

Exclusion criteria

Group 3 (Controls):

  • Current rehabilitation needs are related to post-treatment care or post-discharge rehabilitation.
  • acute or untreated substance use disorder
  • participating in or apply for Kela's musculoskeletal rehabilitation services (A or B) during the next few months

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

Finland · 1 center
  • The Social Insurance Institution of Finland — Helsinki

Identifiers

NCT: NCT06749509 · KELA_4822_2024

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗